George W. Lloyd, EVP, Investments & GC at Royalty Pharma plc (RPRX), sold 125,100 shares at $43.76 ($5.4M) on 2022-07-27, disclosed to the SEC on 2022-07-27.
Open-market sale of $5.4M RPRX by EVP, Investments & GC. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $42.90 | 19,557 | $839K | 15.5% |
| 2 | $42.90 | 19,557 | $839K | 15.5% |
| 3 | $42.98 | 11,114 | $478K | 8.8% |
| 4 | $42.98 | 11,114 | $478K | 8.8% |
| 5 | $43.03 | 5,443 | $234K | 4.3% |
| 6 | $43.03 | 5,443 |
| $234K |
| 4.3% |
| 7 | $43.12 | 13,886 | $599K | 11.1% |
| 8 | $43.12 | 13,886 | $599K | 11.1% |
| 9 | $43.76 | 25,000 | $1.1M | 20.3% |
| 10 | $43.90 | 100 | $4K | 0.1% |
| Total | $43.15 avg | 125,100 | $5.4M | 100% |
| Filing → |
| RPRX | SELL | 2025-11-21 | $10.4M | — | Filing → |
| RPRX | SELL | 2023-06-06 | $13.0M | — | Filing → |
| RPRX | SELL | 2023-03-30 | $4.7M | — | Filing → |